細胞死制御剤による重粒子放射線防護効果のマウス個体レベルでの検討

Morita Akinori, 越智進太郎, 村上正弘, 下川卓志, Mitsuru Nenoi, Ochi Shintaro, Kaoru Tanaka(Kindai University), 田中薫, 根井充, 勝部孝則, 王冰, Masahiro Murakami, Bing Wang, 森田明典, Takashi Shimokawa(National Institutes for Quantum Science and Technology), ラマダーニ・ドゥウィ, Takanori Katsube(National Institutes for Quantum Science and Technology)

Institutional Repositories DataBase (IRDB)

April 17, 2018

Cited by 0

Related Papers

Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer

|JAMA Oncology|2017|1k

Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment

|Annals of Oncology|2017|294

Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer

|Clinical Cancer Research|2020|244

Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

|Journal of Thoracic Oncology|2017|227

Space Radiation Biology for “Living in Space”

|BioMed Research International|2020|181